Alfonso Gómez de Liaño

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.9K citations

Pharmacy, Oncology, Pharmacotherapy +14

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 416 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer

Alfonso Gómez de Liaño, Nick van Dijk, Guillermo de Velasco et al. · European Urology · 2019 · 62 citations

Medicine, Clinical Sciences, Oncology +15

SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)

Begoña P. Valderrama, Aranzazu González del Alba, Rafael Morales‐Barrera et al. · Clinical & Translational Oncology · 2022 · 17 citations · Full text

Medicine, Oncology, Surgery +10

Patient Perspective on the Management of Cancer Pain in Spain

Jesús García‐Foncillas, Antonio Antón-Torres, Fernando Caballero‐Martínez et al. · Journal of Patient Experience · 2020 · 11 citations · Full text

Medicine, Oncology, Cancer Pain Management +11